Protak Scientific invest in new premises

Published: 23-May-2018
Estates & Facilities Pharmaceutical

Protak Scientific will shortly be moving to brand new offices in Merstham, Surrey


Protak Scientific announced that it will be shortly moving to brand new offices in Merstham, Surrey.

Investing more than a million pounds is never an easy decision, said the company. However, it is the natural progression to support its growing multinational pharmaceutical customer base.

Phillip Godden, CEO of Protak Scientific said: “To support our worldwide growth we have obtained new offices in Merstham Surrey, the offices are currently undergoing a refurbishment programme, which will see the installation of a graded and qualified GMP facility for long-term production."

“We are investing in our success so far with a facility that will support our long-term growth and that of our distributors worldwide."

  • Companies:
  • Protak Scientific
See more

You may also like

Analysis

Phillip Godden speaks up about Enzyme Indicator technology

Read more
What is the market penetration of the EI technology and why should companies consider the new method for bio-decontamination validation? Phillip Godden, Protak Scientific CEO, answers these questions and comments on the support received by the MHRA

Trending Articles

  1. Drive for innovation: New biologicals development centre of Boehringer Ingelheim Boehringer Ingelheim, a leading research-driven biopharmaceutical company, is dedicated to advancing innovation in areas with significant medical needs. With its primary research and development centre based in Biberach, the company employs approximately 7,500 individuals who are focused on creating human pharma, as well as animal health products
  2. UPDATE: US Pharmacopeia makes comments public on endotoxin testing overhaul The USP has published the comments the organisation received in response to the addition of non-animal derived endotoxin testing methods, as well as an FAQ page on the issue
  3. BES completes Terumo Aortic cleanroom build started pre-covid Cleanroom construction expert has finished the 2,400 sqm manufacturing facility with cGMP cleanrooms for the medical device manufacturer
  4. FDA Warning Letter: ImprimisRx facility features stained HEPA filters Following a 2022 inspection, ophthalmic medicine production expert ImprimisRx received a 483 form. A year later a warning letter has been sent emphasising major issues with the facility design and operation
  5. The importance of growth promotion testing Given the critical nature of microbiological quality tests which are employed to ensure that pharmaceutical products are safe for human use, it is in turn essential to undertake quality control (QC) tests to ensure that the culture media being used for these is fit for purpose and performs properly. Cherwell Laboratories' Steven Brimble explains

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Analysis

Phillip Godden speaks up about Enzyme Indicator technology

What is the market penetration of the EI technology and why should companies consider the new method for bio-decontamination validation? Phillip Godden, Protak Scientific CEO, answers these questions and comments on the support received by the MHRA
Design & Build

Drive for innovation: New biologicals development centre of Boehringer Ingelheim

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, is dedicated to advancing innovation in areas with significant medical needs. With its primary research and development centre based in Biberach, the company employs approximately 7,500 individuals who are focused on creating human pharma, as well as animal health products
Design & Build

BES completes Terumo Aortic cleanroom build started pre-covid

Cleanroom construction expert has finished the 2,400 sqm manufacturing facility with cGMP cleanrooms for the medical device manufacturer
Regulatory

UPDATE: US Pharmacopeia makes comments public on endotoxin testing overhaul

The USP has published the comments the organisation received in response to the addition of non-animal derived endotoxin testing methods, as well as an FAQ page on the issue
Design & Build

Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies

Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
Design & Build

WuXi XDC chooses Pharmadule for modular ADC facility build

Modular pharmaceutical build expert Phamadule has shipped nearly 100 ADC production modules to WuXi XDC's Singapore manufacturing site
Finance

Azbil completes transfer of aseptic process solutions to expert Telstar to Syntegon

Japan-based Azbil Corporation has officially transferred all of the equity interests in its European subsidiary Azbil Telstar to a wholly owned subsidiary of Syntegon Technology
Subscribe now